Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04364048 |
| Title | Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung Cancer |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Rachel Sanborn |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Rush University Medical Center | Chicago | Illinois | 60612 | United States | Details | |
| Cancer Center of Kansas | Wichita | Kansas | 67214 | United States | Details | |
| HealthPartners Institute | Minneapolis | Minnesota | 55440 | United States | Details | |
| Summit Medical Group, P. A. | Berkeley Heights | New Jersey | 07922 | United States | Details | |
| Providence Portland Medical Center | Portland | Oregon | 97213 | United States | Details |